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Abstract
Background: Grass carp reovirus (GCRV), which causes severe infectious outbreaks of hemorrhagic disease in
aquatic animals, is a highly pathogenic agent in the Aquareovirus genus of family Reoviridae. The outer capsid shell
of GCRV, composed of the VP5-VP7 protein complex, is believed to be involved in cell entry. The objective of this
study was to produce a major neutralization antibody for mitigating GCRV infection.
Results: Recombinant plasmids of GCRV outer capsid proteins VP5 and VP7 were constructed and expressed in
prokaryotic cells in our previous work. In this study, we prepared GCRV Antibody (Ab), VP5Ab and VP7Ab
generated from purified native GCRV, recombinant VP5 and VP7 respectively. Immunoblotting analysis showed that
the prepared antibodies were specific to its antigens. In addition, combined plaque and cytopathic effect (CPE)-
based TCID50 (50% tissue culture infective dose) assays showed that both VP5Ab and VP7Ab were capable of
neutralizing viral infectivity. Particularly, the neutralizing activity of VP7Ab was 3 times higher than that of VP5Ab,
suggesting that VP7 might be a dominating epitope. Moreover, the combination of VP5Ab and VP7Ab appeared to
enhance GCRV neutralizing capacity.
Conclusions: The results presented in this study indicated that VP7 protein was the major epitope of GCRV.
Furthermore, VP5Ab and VP7Ab in combination presented an enhanced capacity to neutralize the GCRV particle,
suggesting that the VP5 and VP7 proteins may cooperate with each other during virus cell entry. The data can be
used not only to further define the surface epitope domain of GCRV but may also be applicable in the designing
of vaccines.
Background
Grass carp reovirus (GCRV), a member of genus Aqua-
reovirus in the family Reoviridae[1], was the first viral
pathogen to be identified from aquatic animals in China;
this virus was identified twenty years ago during an
acute epidemic characterized by symptoms of hemorrha-
gic disease in fingerling and yearling grass carp [2,3]. In
an attempt to control the spread of this disease, pro-
gress has been made using a crude inactive vaccine pre-
paration, but the agent is far from being effective in the
prevention of GCRV viral infection. In addition, GCRV
has been recognized as the most pathogenic of the iso-
lated aquareoviruses reported to date [4,5]. Therefore, it
is important to develop an effective vaccine for better
prevention and control of fatal outbreaks of hemorrha-
gic disease.
The GCRV is a nonenveloped icosahedral particle
comprising 11 double-stranded RNA genome segments
surrounded by multiple concentric protein capsids [6].
The 11 genome segments encode seven structural pro-
teins (VP1-VP7) and five nonstructural proteins [7,8].
Although the 11-part segmented genome of GCRV is
similar in composition to members of the genus Rota-
virus within the family Reoviridae, there is no genetic
relationship with rotavirus based on reciprocal RNA-
RNA dot blot hybridization [9,10]. Previous biological
studies have indicated that the GCRV can produce a
typical cytopathic effect (CPE) with large syncytia in its
sensitive cells [11]. In addition, the virions are resistant
to chloroform and ether, insensitive to acid (pH 3) and
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alkaline (pH 10) treatment; they are also stable within
an extensive range of temperatures [12], which suggest
that the virus is very stable in harsh natural environ-
ments. Recent cryo-electron microscopy (cryo-EM) and
three-dimensional (3D) structural reconstruction images
indicate that the inner layer arranges with a T = 1 sym-
metry. This layer is composed of 5 proteins (including
VP1-VP4 and VP6) and possesses the enzymatic activ-
ities necessary for viral transcription [6,7,13,14]. The
other outer capsid proteins, arranged on an incomplete
T = 13 icosahedral lattice, are composed of VP5 and
VP7; each GCRV virion contains 200 trimers formed by
VP5-VP7 heterodimers, a structure homologous to the
μ13s33 complex of MRV (Mammalian reovirus)[13,15].
Similar to μ1 protein in MRV, the VP5 protein can exist
in two conformations in virions and infectious subviral
particle (ISVP); these conformations are thought to be
caused by autocleavage near the N-terminus between
amino acid residues Asn42 and Pro43 [16-20]. Protein
VP7, the major surface protein of virions, adopts icosa-
hedral positions through its close interactions with
underlying VP5 subunits, providing stability for the vir-
ion or VP5 protein, a function similar to that of s3 pro-
tein of MRV [13]. However, GCRV lacks a counterpart
to the MRV protein s1, which functions as a cell attach-
ment protein and is situated on each fivefold vertex
[7,13]. Meanwhile, biological experiments have shown
that the complete digestion of VP7 and partial cleavage
of VP5 lead to enhanced infectivity, suggesting that VP7
and VP5 may play important roles in virus entry into
cells [16]. Notably, recent progress on the GCRV infec-
tious subviral particle 3.3 Å atom structure revealed a
priming mechanism of dsRNA virus entry into cells [17].
To gain insight into defining the GCRV major neutrali-
zation epitope and find an effective way to inhibit viral
infection, the effects of neutralizing antibodies directed
against VP5 and VP7 proteins were investigated in this
study. Previously, we constructed the recombinant outer
capsid proteins VP5 and VP7 of GCRV and expressed
His-tag fusion proteins in E. coli [21,22]. In the present
work, we expressed His-tag fusion VP5 and VP7 protein
in a large scale and then purified the fusion proteins. In
addition, we examined the neutralization ability of the
GCRV antibody, VP5Ab, VP7Ab individually, and VP5Ab
and VP7Ab in combination, respectively. We found that
the specific GCRV antibody, VP5Ab and VP7Ab are cap-
able of neutralizing viral infectivity. Particularly, the neu-
tralizing activity of VP7 antiserum is 3 times higher than
that of VP5, suggesting the VP7 might be the dominating
epitope. Moreover, the combination of VP5 and VP7 anti-
bodies showed enhanced neutralizing capacity to GCRV.
The result reported in this study can help not only to
further define GCRV surface epitopes, but they may also
contribute toward the design of subunit vaccines.
Methods
Cell and virus
The CIK(Ctenopharyngodon idellus kidney)cell line,
established by Zuo et. al [23], was used for the propaga-
tion of grass carp reovirus (GCRV). The GCRV873
strain, maintained in the author’s laboratory, was used
in this study [11,12]. The cells and viruses were culti-
vated according to previously described methods [11].
Virus purification and transmission electron microscopy
GCRV particles from infected culture supernatant were
purified using an established method [6]. The concen-
trations of purified viral particles from virus infected cell
supernatants were measured using a spectrophotometer
(Biotek, USA) following the instruction manual of the
instrument. For examination by transmission electron
microscopy (TEM), the purified viral particles were
negatively stained with 3% (w/v) phosphotungstic acid
(PTA, pH 6.8). All the sample grids were examined by
transmission electron microscopy (Hitachi 7000-FA).
Expression and purification of the recombinant VP5 and
VP7 proteins in E. coli
To produce purified recombinant VP5 and VP7 on a
large scale, the amplified genes of interest were cloned
into the pRSET-A vector (named as pR/GCRV-VP5 and
pR/GCRV-VP7) [21,22]. The constructed recombinants
were transformed into BL21(DE3) pLysS cells, which
were propagated in a large scale culture. For time course
expression, the cells were induced with 1 mM IPTG
(Isopropyl b-D-1-thiogalactopyranoside) at 37°C. All the
cultured bacteria were collected and lysed and the cell
lysate extracts were resuspended in phosphate-buffered
saline (PBS, 137 mM NaCl, 2.7 mM KCl, 8.1 mM
Na2HPO4, 1.5 mM KH2PO4; pH 7.5). The suspensions
were mixed with 2 × SDS sample buffer for further
characterization by sodium dodecylsulfate-polyacryla-
mide gel electrophoresis (SDS-PAGE) as described else-
where [16]. Because of the presence of a His-tag region
in the N-terminus of the recombinant fusion protein,
affinity purification of the protein could be performed.
For the purification, the ProBond™ Resin Purification
System (Invitrogen, USA) was used according to the
manufacturer’s instructions.
Preparation of antisera and ELISA
The purified recombinant proteins VP5 and VP7 and
the gradient-purified GCRV sample were used as anti-
gens to raise antibodies in the New Zealand white rab-
bit. VP5Ab, VP7Ab and GCRV antibody were obtained
by immunization of rabbits with purified native GCRV,
His-VP5 and His-VP7 fusion proteins respectively. The
titers of the antibodies were determined by using ELISA
(Enzyme-linked immunosorbent assay) as described
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elsewhere [22]. Each antiserum dilution was assayed in
duplicate with three repeats.
SDS-PAGE and Western blotting analysis
The samples used for protein analysis were subjected to
12% sodium dodecylsulfate-polyacrylamide gel electro-
phoresis (SDS-PAGE) as described above. Proteins were
visualized by using 0.25% Coomassie brilliant blue R-
250 (Sigma). Western blotting analysis was used to
detect the specificities of the expressed proteins. We
used either His-tag (mouse) or GCRV, VP5, VP7 protein
antibodies (rabbit) against the appropriate epitope as the
primary antibody. Alkaline phosphatase-coupled rabbit
anti-mouse and goat anti-rabbit IgG were used as the
secondary antibodies. All the results were observed by
developing with AP substrate solution (NBT/BCIP).
Infection and determination of virus titer
GCRV was inoculated in CIK cells with a virus stock at
10 MOI (multiplicity of infection). The titer of GCRV
was determined by using CPE-based TCID50 (50% tissue
culture infective dose) or plaque assays as described
elsewhere [24]. Virus stock was serially diluted 1:10 in 1
x PBS, and the diluted virus stock was inoculated in tri-
plicate onto confluent monolayers of CIK cells. Infected
cells were incubated at 28°C in MEM-2 (MEM with 2%
FBS, named MEM-2) for 3 days. Virus infectivity was
measured by calculating the TCID50, and the endpoints
were calculated by the methods of Reed & Muench [25].
Neutralization assay of prepared antibodies
Infectivity of antibody-treated virus was determined by
both plaque and CPE-based TCID50 assays. Briefly, native
GCRV antibody, VP5Ab and VP7Ab were heat inactivated
at 56°C for 30 min and diluted with Eagle’s MEM medium
with doubling dilutions. Nine serial twofold dilutions (1:8 -
1:2048) were used for the neutralization test. Cells infected
with 100 TCID50 GCRV virions that were titered as
described above, and mock-infected cells served as positive
and negative controls, respectively. For the neutralization
assay, 100 μl antiserum and 100 μl virus (containing 100
TCID50 virions) were added to each well of 24-well micro-
titer plates and mixed gently, followed by incubating the
mixture at 37°C for 60 min, and the next neutralization
test was performed as described elsewhere [16,24]. The
endpoints of neutralization antibody titers were deter-
mined by the Reed-Muench method [25]. For plaque
assays, the specific reduction in virus infectivity was calcu-
lated as the percent of plaque reduction. TCID50 assays
used for determining virus titers in this study were the
averages obtained from triple determinations for each
sample with three or four repeats.
Results
Analysis of protein components of GCRV particles
To identify purified virion preparations, the GCRV sam-
ples obtained by cesium chloride (CsCl) density gradient
centrifugation from infected cell culture supernatant
were observed using transmission electron microscopy
(TEM). Purified virions had a clear double capsid shell
morphology and structure organization with a size of
approximately 80 nm in diameter (Figure 1A). To further
verify the components of purified GCRV, the virus sam-
ple was analyzed by SDS-PAGE (Figure 1B). The purified
virus sample appeared to contain seven capsid proteins
VP1-VP7, indicating that the purified native GCRV pre-
paration can be used as an antigen to immunize animals.
Purification and identification of expressed recombinant
proteins
Previously, we have successfully expressed VP5 and VP7
protein in E. coli [17,18]. To make a large-scale
Figure 1 Purified GCRV particles and their protein components. A: Purified GCRV particles observed by TEM; B: SDS-PAGE analysis of GCRV
structural proteins.
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preparation for further immunogen analyses, the highly
expressed recombinant His-tag fusion proteins of VP5
and VP7 were purified using the ProBond™ resin purifi-
cation kit. As shown in Figure 2, the purified VP5
(about 70 kDa) and VP7 proteins (about 35 kDa) were
the products of interest. Western blotting analysis
showed that expressed His-tag fusion proteins VP5 and
VP7 could bind to the anti-His-tag antibody(mouse),
demonstrating that the in vitro-expressed recombinant
products were the His-tag fusion proteins of interest
(data not shown).
Titration of prepared antisera and specific analysis
Purified recombinant VP5 and VP7 proteins and native
GCRV particles were immunized into the New Zealand
white rabbit. After twice-enhanced immunization, the
primary titer of the antiserum was tested. Further titers
of VP5Ab, VP7Ab and GCRV antibody were determined
with antigen-coated GCRV particles using ELISA. It was
found that the minimum OD405 values of polyclonal
anti- GCRV, VP5 and VP7 sera at a dilution of 1:1000
were above 0.42, 0.32 and 0.35, respectively, which was
about 3 times higher than the value for normal rabbit
serum (Figure 3), indicating that the in vitro-expressed
VP5 and VP7 had good immunogenicity.
To further access whether the prepared VP5 and VP7
polyclonal antisera could be recognized by native GCRV
antigen, western blotting analyses were performed. It
appeared that purified VP5 and VP7 recombinant pro-
teins could bind to the GCRV antibody; no visible band
could be detected from the expression of empty vector,
demonstrating that the expressed VP5 and VP7 proteins
were specific to GCRV antibody, as shown in Figure 4A.
Furthermore, GCRV particles could be immunologically
recognized by VP5Ab and VP7Ab, whereas un-infected
CIK cell lysate had no cross-immunological reaction
with VP5Ab and VP7Ab, suggesting that the VP5Ab
and VP7Ab are specific to GCRV.
Neutralization assay of tested antibodies
As indicated above, GCRV antibody, VP5Ab and VP7Ab
all had comparatively high titers according to ELISA
detection. To evaluate the neutralization ability of the
prepared antibodies to GCRV infection, neutralization
assays were performed with GCRV antibody, VP5Ab,
VP7Ab individually and VP5Ab and VP7Ab in combina-
tion, respectively. The neutralization titers of four tested
sera varied in the following order: native GCRV > VP5
+VP7 > VP7 > VP5 (as shown in table 1). The 50% neu-
tralization titer of the single VP7Ab was 1/210, which
was 3 times higher than that of VP5Ab. This suggests
that the VP7 protein might be the dominating epitope,
and VP7 expressed in E. coli has good immunogenicity.
Moreover, the combination of VP5Ab and VP7Ab had a
50% neutralization titer of 1/350, hinting that VP5Ab
may have a compensatory effect to neutralize intact
GCRV particle or ISVP infectivity.
Discussion
Non-enveloped virus attachment and entry into host
cells are multiple steps that influence cellular tropism
and can involve sequential recognition of multi-recep-
tors. Studies on the GCRV genome and 3D structure
have revealed that the VP5 and VP7 proteins comprise
the outer capsid shell of the virus, which resemble the
μ1 and s3 proteins in MRV, respectively, in both pro-
tein homology and particle location. Similar to MRV μ1
and s3, the outer-capsid proteins VP5 and VP7 play cri-
tical roles in virus entry [13,15,26]. In MRV, the first
step in entry is binding to cell surface receptors, which
is mediated by the s1 trimer located at each fivefold
axis in the virions [27]. Due to the lack of the s1
Figure 2 Expression and purification of recombinant VP5 and VP7. M, Standard protein marker; Lane 1 and Lane 5, empty vector control;
Lanes 2-4, VP5 cell lysate extracts induced by IPTG for 1, 3 and 5 h, respectively; Lanes 6-8, VP7 cell lysate extracts induced by IPTG for 1, 3 and
5 h, respectively; Lanes 9-10, purified VP5; Lanes 11-12, purified VP7. All of the total cell extracts and purified proteins were electrophoresed on a
12% SDS-polyacrylamide gel followed by staining with 0.25% Coomassie brilliant blue R-250.
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protein in GCRV, the outermost protein VP7 may func-
tion to bind cell receptors to initiate infection. Following
binding, the major outer-capsid proteins VP7 and VP5
are proteolytically cleaved to yield metastable ISVP. This
leads to VP5 structural rearrangement through confor-
mational change in order to penetrate cell membrane.
We found that the neutralizing activity of VP7 anti-
serum was 3 times higher than that of VP5 antiserum,
which was also confirmed by single chain fragment of
variable (scFv) antibodies against Grass Carp IgM (Chen
et al., unpublished data), suggesting that VP7 might be
a major antigen determinant. Given this result, it is pro-
posed that VP7 may act as a cell attachment protein to
bind to the cell receptor, because VP7 is located at the
outermost layer of the particle. The effective combina-
tion between antigen and antibody may block out the
cell attachment site and prevent virus infection. It
appeared that the neutralization titers induced by VP5
and VP7 (1:70 and 1:210, respectively) were lower than
that of native intact virus (1:460). This may be due to a
variation in VP5 and VP7 protein conformation or fold-
ing in E. coli expression from that of the natural VP5
Figure 3 Titration of the polyclonal VP5Ab, VP7Ab and GCRV antibody by ELISA. All the tested samples are marked with different colors.
Figure 4 Western blotting analysis of expressed proteins VP5, VP7 and GCRV. A: Western blotting analysis of expressed VP5 and VP7 cell
lysate extracts in E. coli with native GCRV antibody. M, Standard protein marker; Lane 1, empty vector cell lysate extracts induced with IPTG for 3
h as negative control; Lanes 2-3, VP7 cell lysate extracts induced by IPTG for 3 h; Lanes 4-5, VP5 cell lysate extracts induced with IPTG for 3 h.
The long arrowhead indicates VP5 and short arrowhead indicates VP7. B: Western blotting of purified GCRV with VP5Ab and VP7Ab; Lane 1,
purified native GCRV particles with VP5Ab; Lane 3, purified native GCRV particles with VP7Ab; Lane 2, un-infected CIK cell as negative control.
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and VP7. The neutralization titer in combination with
VP5Ab and VP7Ab was higher than that of a single
antibody, suggesting that GCRV infection is not depen-
dent upon a single viral protein or cell factor. In this
way, VP7 antiserum may target neutralizing intact parti-
cles, while VP5 antibody is preponderant to neutralize
ISVP. The fact that the neutralization titer of VP5Ab
and VP7Ab combined was higher than that of single
antibody suggests that there is one more receptor-bind-
ing site on GCRV surface proteins. Furthermore, the
result is also consistent with a previous report that
revealed that removing the outermost capsid protein
(VP7) of an aquareovirus was associated with increased
infectivity [28], indicating that the VP5 and VP7 pro-
teins of GCRV are possibly involved in initiating viral
infection. Notably, sequence alignment and structural
comparison with l2 in MRV suggest that the GCRV
VP1 turret structure can be divided into a GTase(guany-
lyltransferase)domain, two methylase domains, and an
immunoglobulin (Ig)-like flap domain. The most signifi-
cant difference between MRV l2 and GCRV VP1 was
observed in the Ig-like flap domain. In this regard, it is
postulated that the VP1 flap domains might also be
involved in conferring host specificity during virus entry
into cells.
In this study, we prepared GCRV, VP5 and VP7 poly-
clonal antibodies generated from purified native GCRV,
recombinant VP5 and VP7. Our results indicated that
the prepared antibodies were specific and immunologi-
cally related to the GCRV epitope, and cross-reaction of
the antibodies to GCRV particles could be detected by
western blotting analysis. In addition, both VP5Ab and
VP7Ab were capable of neutralizing viral infectivity,
evaluated using CPE-based TCID50 and plaque assays.
Moreover, the neutralizing activity of VP7 antiserum
was 3 times higher than that of VP5Ab, suggesting that
VP7 might be the dominating epitope. Furthermore, the
combination of VP5Ab and VP7Ab presented an
enhanced neutralizing capacity to GCRV. The data can
be used to further define the surface epitope domains of
GCRV and may have significant applications for vacci-
nating against GCRV infection.
Conclusions
The results presented in this study showed that the
antiserum of VP7 protein had a higher neutralization
ability than that of VP5 antiserum, while the combina-
tion of VP5Ab and VP7Ab had a stronger capacity to
neutralize GCRV than either antibody singly. This
study not only lays a foundation for further vaccine
design, but also provides a framework for further
investigation of the neutralization mechanisms of
aquareoviruses.
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